Xitao Xu

NHC Key Laboratory Of Digestive Diseases, State Key Laboratory Of Systems Medicine For Cancer
Shanghai, 200001, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications

Microbial phosphoketolase promotes histone lactylation to improve anti-TNF therapy efficacy in inflammatory bowel disease.

Microbial phosphoketolase promotes histone lactylation to improve anti-TNF therapy efficacy in inflammatory bowel disease.

Journal: Cell metabolism
Published: September 21, 2025

Bacteroides fragilis Toxin Suppresses METTL3-Mediated m6A Modification in Macrophage to Promote Inflammatory Bowel Disease.

Bacteroides fragilis Toxin Suppresses METTL3-Mediated m6A Modification in Macrophage to Promote Inflammatory Bowel Disease.

Journal: Journal of Crohn's & colitis
Published: March 11, 2025

Antinuclear antibodies seroconversion and endoscopic response to infliximab in biologic-naive Crohn's disease: a Chinese single-center, retrospective study.

Antinuclear antibodies seroconversion and endoscopic response to infliximab in biologic-naive Crohn's disease: a Chinese single-center, retrospective study.

Journal: Intestinal research
Published: February 04, 2025

CT enterography for evaluation of disease activity in patients with ileocolonic Crohn's disease.

CT enterography for evaluation of disease activity in patients with ileocolonic Crohn's disease.

Journal: BMC gastroenterology
Published: November 14, 2021

Efficacy of early intervention on the bowel damage and intestinal surgery of Crohn's disease, based on the Lémann index.

Efficacy of early intervention on the bowel damage and intestinal surgery of Crohn's disease, based on the Lémann index.

Journal: BMC gastroenterology
Published: September 07, 2020

Long noncoding RNA TCONS_00026334 is involved in suppressing the progression of colorectal cancer by regulating miR-548n/TP53INP1 signaling pathway.

Long noncoding RNA TCONS_00026334 is involved in suppressing the progression of colorectal cancer by regulating miR-548n/TP53INP1 signaling pathway.

Journal: Cancer medicine
Published: July 06, 2020

Effectiveness of Infliximab on Deep Radiological Remission in Chinese Patients with Perianal Fistulizing Crohn's Disease.

Effectiveness of Infliximab on Deep Radiological Remission in Chinese Patients with Perianal Fistulizing Crohn's Disease.

Journal: Digestive diseases and sciences
Published: December 12, 2019

Evaluating the effectiveness of infliximab on perianal fistulizing Crohn's disease by magnetic resonance imaging.

Evaluating the effectiveness of infliximab on perianal fistulizing Crohn's disease by magnetic resonance imaging.

Journal: Gastroenterology report
Published: April 04, 2018
Showing 1-8 of 8

Last Updated: 09/26/2026